CDMO
Avid Bioservices Inc (CDMO)
$15.780.77%▲
Market is closedMarket is closed – opens on 8 PM, 02 Dec 2022
– opens on 8 PM, 02 Dec 2022
Key Stats
$15.24
Day's Range
$15.99
$11.3
52-Week Range
$32.03
| Returns | |
| 1 month return | 0.57% |
| 3 month return | 10.51% |
| 1 year return | 48.74% |
| 5 year return | 201.15% |
Company Information
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 28 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization
| Organization | Avid Bioservices Inc |
| Employees | 321 |
| CEO | Mr. Nicholas Stewart Green B.Sc., MBA |
| Industry | Health Technology |
Analyst Recommendation
based on 4 analysts ratings
Buy
75%
Buy
25%
Hold
0%
Sell
Based on 4 Wall street analysts offering stock ratings for Avid Bioservices Inc(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 64.77%Current
$15.78
Target
$26.0
Recommendation Trend
Based on 4 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 3 | 8 | 8 |
| Hold | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 915.1M |
| Book Value | $2.88 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | 1.79 |
| PE Ratio | 8.22 |
| Wall Street Target Price | 26.0 |
Valuation
| Trailing PE | 8.22 |
| Forward PE | 185.19 |
| Price/Book (mrq) | 5.11 |
| Enterprise Value | 981.4M |
| Enterprise Value/Revenue | 7.82 |
| Enterprise Value/Ebitda | 60.65 |
Technicals
| Beta | 1.82 |
| 50 Day MA | 16.42 |
| 200 Day MA | 17.03 |
Institutional Holdings
FMR Inc
9.79%
Vanguard Group Inc
6.79%
State Street Corporation
6.24%
Jennison Associates LLC
4.63%
AltraVue Capital, LLC
4.32%
Ranger Investment Management LP
3.39%
Discover more
Frequently Asked Questions
What is Avid Bioservices Inc share price today?
Can Indians buy Avid Bioservices Inc shares?
How can I buy Avid Bioservices Inc shares from India?
Can Fractional shares of Avid Bioservices Inc be purchased?
What are the documents required to start investing in Avid Bioservices Inc stocks?
What are today’s High and Low prices of Avid Bioservices Inc?
What are today’s traded volumes of Avid Bioservices Inc?
What is today’s market capitalisation of Avid Bioservices Inc?
What is the 52 Week High and Low Range of Avid Bioservices Inc?
How much percentage Avid Bioservices Inc is down from its 52 Week High?
How much percentage Avid Bioservices Inc is up from its 52 Week low?
What are the historical returns of Avid Bioservices Inc?
Who is the Chief Executive Officer (CEO) of Avid Bioservices Inc?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*